C3i at Effervescence Montréal 2025: A Must-Attend Event for Innovative Therapies

An active presence at the heart of discussions on regenerative medicine

On April 30, Yvan Côté, President and CEO of C3i, took part in Effervescence Montréal 2025, a key event bringing together key players from research, innovation, and the life sciences industry. Organized by ThéCell – Québec’s Cell, Tissue and Gene Therapy Network, this year’s workshop focused on the latest advancements in regenerative medicine and innovative therapies, a theme that fully aligns with C3i’s mission to make cell and gene therapies accessible to patients. The day was marked by rich and engaging conversations, where researchers, entrepreneurs, and industry experts shared visions, challenges, and avenues for collaboration to accelerate the clinical deployment of these cutting-edge therapeutic approaches.

At C3i, we are proud to be part of this dynamic ecosystem and to actively contribute to shaping the future of healthcare in Québec.